GABRG3 antisense RNA 2 (GABRG3-AS2)

GABRG3 antisense RNA 2 (GABRG3-AS2) is a long non-coding RNA gene that is transcribed from the antisense strand of the genomic region overlapping or adjacent to the GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3) gene[3]. Antisense RNAs, especially those classified as lncRNAs, are typically involved in the regulation of their corresponding sense genes through complementary base-pairing, potentially affecting transcription, splicing, mRNA stability, or translation[2]. The precise biological function, disease relevance, and molecular partners of GABRG3-AS2 remain uncharacterized as of current knowledge[3]. This gene is not considered a canonical therapeutic target, receptor, enzyme, or transporter. There are no drugs, established biomarkers, or known safety concerns directly associated with this RNA. Additional context: - GABRG3, the sense gene counterpart, is important in neurobiology and is associated with diseases such as Angelman Syndrome and Autism Spectrum Disorder[1][4]. - GABRG3-AS2 should not be confused with the protein-coding GABRG3 gene or the GABA-A receptor; it is a non-coding RNA and not a receptor or an enzyme[3]. - Its function is inferred from the general roles of antisense RNAs, which often regulate gene expression via interaction with complementary sense transcripts[2]. No therapeutic targeting or validation exists for GABRG3-AS2.

Not applicable; no known drugs target GABRG3-AS2.